Rapid laboratory diagnosis of mumps virus infections is important for the management of patients with suspected mumps meningoencephalitis or orchitis. The demonstration of specific immunoglobulin M (IgM) antibody is considered to be a useful tool for the rapid diagnosis of virus infections since as a rule, this antibody is detectable only for a limited period. Indirect tests, including the immunofluorescence test (1, 2) , a radioimmunoassay (5) , and an enzyme-linked immunosorbent assay (11, 14) , have been used to detect mumps-specific IgM. A problem with indirect tests for determining virus-specific IgM in whole sera is that IgG antibody may inhibit the binding of IgM antibody, particularly when high titers are present, thus giving false-negative results. Furthermore, rheumatoid factor (RF) of the IgM class may cause false-positive results by reacting with antigen-IgG complexes. These problems may be overcome by separating IgM from IgG. A method which is being used increasingly to separate IgM from other serum constituents involves a solid phase coated with antihuman IgM (9) . After the serum of a patient is added, IgM is bound to the sensitized solid phase.
Recently, we developed a hemadsorption immunosorbent technique (HIT) to detect rubellaspecific IgM antibody; this technique uses the same principle for the separation of IgM (15 HIT. We used the procedure described previously to detect rubella IgM (15), with some modifications. Serial twofold dilutions of serum were made in antihuman IgM-coated plates in HEPES-saline-albumin buffer containing 0.01 M HEPES (N-2-hydroxyethylpiperaz.ine-N'-2-ethanesulfonic acid) hydrochloride (pH 6.8), 0.85% NaCl, and 1% bovine serum albumin (Cohn fraction V; ICN Pharmaceuticals, Inc., Cleveland, Ohio). The starting serum dilution (final volume, 0.1 ml/well) was 1: 40. After incubation at 37°C for 2 h, the plates were washed four times with tap water, and 1 U of mumps hemagglutinating antigen in 25 ,ul of HEPES-saline-albumin was added to each well. After overnight incubation at 4°C, 0.1 ml of a 0.07% suspension of guinea pig erythrocytes in HEPES-salinealbumin buffer was added. After standing at room temperature for 2 h, the plates were centrifuged at 400 x g for 10 min and read. A serum showing hemadsorption at a dilution of 1: 160 or higher was considered to contain mumps-specific IgM, whereas a serum showing hemagglutination was considered negative. The hemadsorption and hemagglutination patterns were similar to the patterns of the HIT assay for rubella IgM illustrated previously (15) . The sera from patients with mumps infections or other illnesses examined in this study were either negative as determined by the HIT test at a dilution of 1:20 or positive at dilutions of 1: 160 and higher.
Other serological tests. The CF procedure used was the microtechnique described by Casey (4) . HI tests were performed by the microtiter technique of Dowdle et al. (6) . IgM-RF was measured by a direct enzymelinked immunosorbent assay, as described previously (15) . In addition, a latex fixation test adapted to microtiter plates was used to estimate RF (8) . To determine the specificity of the HIT for the IgM class of antibody, sera were fractionated by sucrose density gradient centrifugation (15) .
Antigens. The Enders strain of mumps virus was propagated in chicken embryos. HI and HIT tests were performed with crude allantoic fluid from infected chicken embryos or with such material after it was treated with Tween 80 and ether (3, 12 There was no evidence of a significant effect of nonspecific inhibitors or inactivation of sera in the HIT test. The HIT test titers of 10 sera from patients with recent mumps infections remained the same after pretreatment with a receptor-destroying enzyme or inactivation at 56°C for 30 min. Treatment with Tween 80 and ether increases the hemagglutinating activity of paramyxoviruses (3, 12) . We tested 30 sera with mumps IgM in the HIT assay against untreated and Tween 80-ether-treated mumps antigens. On the whole, the titers varied twofold or less with the two antigen preparations.
Effect of RF. RF did not give false-positive results in the HIT assay. Eight sera (group 2) with HI antibody titers of 20 to 80 for mumps and low or high levels of RF as determined by the latex fixation test (titers, assay 80 to 10,240) and the enzyme-linked immunosorbent assay for IgM-RF were negative in the HIT assay (titer, <20).
Diagnosis of current mumps infections by the HIT assay. Paired sera from 81 patients with significant increases in mumps CF antibody titers (group 1) were tested by the HIT assay. All 81 patients showed mumps IgM antibody in one or both of the paired sera, with titers ranging from 160 to 327,680. Of the 81 patients, 75 had mumps IgM antibody in their acute-phase sera. In 28 instances IgM antibody was demonstrated in acute-phase sera without detectable CF and HI antibodies. (9, 10, 15) , hepatitis A virus (7), and cytomegalovirus (13, 16) . It is well known that sera from patients with parainfluenza virus infections show cross-reactions in CF and HI tests to mumps virus. In our study 8 (14%) of 57 patients with parainfluenza virus infections showed significant increases in CF antibody to mumps virus, and 5 (9%) showed mumps IgM antibody. In two other studies (11, 14) no CF antibody titer increases and IgM antibodies to mumps virus were found in sera from 23 and 12 patients with parainfluenza virus infections, respectively. One possible explanation for the discrepancy between the results of these studies and our results might be that the antigenic stimulus of the infecting parainfluenza virus was too weak to evoke heterologous antibodies in the patients in the previous studies, perhaps because of less severe illness. It is also possible that the differences were due to a greater sensitivity of the HIT assay for detecting mumps-specific IgM antibody. It seems unlikely that the presence of mumps IgM antibody in our patients resulted from current or recent mumps infections. These patients had no clinical evidence or history of acute or recent mumps infections. Furthermore, the incidence of mumps in The Netherlands is maximal between the ages of 4 and 7 years (17), whereas only one of the five cases with mumps IgM antibody occurred in this age group. The other four patients were 1, 1, 3, and 52 years old. It seems more likely that the appearance of mumps IgM antibody represented a heterologous response to parainfluenza virus infection. The finding that only 1 of 61 patients with illnesses not caused by parainfluenza virus possessed mumps IgM antibody and then at a borderline titer supports this conception.
The HIT test was a sensitive method for the early diagnosis of mumps infections. Most patients showed IgM antibody on day 1 or 2 of illness. Peak titers (in some cases as high as 327,680) were reached in the second and third weeks after the onset of illness. The HIT test is also useful in cases where sera are taken too late for diagnosis by a significant increase in CF titer or where only a convalescent serum is collected.
The findings that prolonged IgM responses to mumps infections may occur occasionally, as shown in the present and previous studies (1, 11) , and that parainfluenza virus infections may elicit IgM antibody to mumps virus in some cases emphasize the importance of interpreting laboratory results in light of clinical and epidemiological details. HIT tests for mumps-specific IgM are particularly valuable for the rapid diagnosis of meningoencephalitis without accompanying parotitis and for confirming clinically suspected cases of mumps (e.g., parotitis and orchitis). In these cases a positive test may be regarded as strong evidence of a mumps infection.
